Drug Analysis Services For Medical Monitoring
-
PremiumManufactured by Powder Systems Limited (PSL)based in UNITED KINGDOM
C.O.P.E.™ is a hub for innovation and collaboration. Based at PSL’s headquarters in Liverpool, UK, the main focus of the facility is to provide a creative, cutting-edge space for process development, where engineers and manufacturers can generate, develop and progress new approaches to production, side by ...
-
by InterXbased in USA
InterX operates at the nexus of academic research and pharma-tech industry. We partner with leading edge researchers, drug developers, and biotechnology companies across the globe to predict drug-target interactions using the most advanced computer algorithms ...
-
Manufactured by Inovotion Sasbased in FRANCE
Over the last decade, high-throughput screening assays have produced thousands of candidate drugs with potential efficacy in pharmacological activity. However, a majority of these drugs have failed during drug development for reasons related to ...
-
based in UNITED KINGDOM
Finding rare events: The Lightcast platform is designed to have a high throughput and will be ideally suited to finding one in 10,000 or one in 100,000 ...
-
based in USA
Unlimited; Scalable, dynamic and cloud-native platform on AWS. Self-Evolving;Periodic updates with new data, knowledge and algorithm. Hands-Free;Simple and customizable work flow design. Secure;End-to-end encryption for user data and ...
-
Manufactured by IDT Biologikabased in GERMANY
IDT Biologika is one of the world’s most experienced CDMOs in terms of expertise in developing and manufacturing of Viral Vaccines, Viral Vectors for Gene and Immune Therapeutics, Oncolytic Viruses, Virus-Like Particles, and other Biologics. We have GMP manufacturing facilities in Europe and the United States, offering capabilities from early-stage development through clinical to commercial ...
-
Manufactured by CELONIC Groupbased in SWITZERLAND
ProJect Pharmaceutics* builds quality into formulation and processes and applies high-throughput predictive stability technologies (Predictive Formulation Analytics, PFA) to ensure manufacturing consistency. Using such a regulatory-compliant Quality by Design (QbD) step at an early stage will result in an accelerated and risk-mediated downstream process (DSP) development. It will also generate a ...
-
Manufactured by Ascendia Pharmaceuticalsbased in USA
Nanotechnology is now being extensively utilized in the development of innovative drug delivery systems for various routes of administration. Due to the advantages of their targeted drug delivery, reduced toxicity, long circulation, and enhanced half-life, nanoparticles are particularly useful for use in long acting formulations. Different types of injectable nanomedicines have been ...
-
based in BELGIUM
The physico-chemical characterisation of your drug substance is the basis of a successful development program. Navigating through the pre-clinical phase is not an easy task. Many compounds fail in early phase development because they are not bioavailable. It is our job to use our pre-formulation development expertise to give your molecule the best chance of success. Our extensive package of ...
-
by Biomcare ApSbased in DENMARK
It is often valuable to study the effect of a product on the gut microbiome or the influence of the microbiome on the effect of a new product, in a controlled setting that eliminates many of the confounding factors that affect the microbiome. Therefore, we offer in vivo tests of new products such as drugs and food ingredients including pre-tox studies, in an integrated workflow with microbiome ...
-
Manufactured by Ascendia Pharmaceuticalsbased in USA
Ascendia specializes in the development of market suitable formulations for poorly water soluble drug substances. Based on the pre-formulation data package and the delivery requirements for the product, we recommend a comprehensive formulation development strategy. We understand that each formulation is unique and must address the specific challenges associated with poor solubility, inadequate ...
-
Manufactured by Ascendia Pharmaceuticalsbased in USA
A 505(b)(2) drug development project represents a streamlined regulatory strategy for many pharmaceutical products today. The provisions of 505(b)(2) were created to avoid unnecessary duplication of studies already performed on a previously approved product. A 505(b)(2) new drug application contains full safety and effectiveness reports on the drug product, but allows information required for ...
-
based in USA
Why is it important to monitor abuse of controlled substances while providing the right care for your pain patients? Prescription medications are necessary to run a practice effectively and providing the right treatment plan is vital to your practice. With prescription drug abuse on the rise, physicians must take action to mitigate risk of running a practice that is highly dependent on controlled ...
-
by Acellerabased in UNITED KINGDOM
This protocol simulates the target of interest (GPCR, kinase, ion channel, etc.) in a solution of water and a co-solvent, like benzene or any other fragment-like molecule. During the simulation, the co-solvent molecules interact with the surface of the protein, revealing binding hotspots. These hotspots have been proven to correlate very well with actual pockets. Furthermore, binding modes for ...
-
Manufactured by Firalis Groupbased in FRANCE
The successful implementation of a biomarker endpoint is highly dependent on the availability of assays and on reliable measurements of markers in biological samples. While a large number of assays are on the market, scientists often have an urgent need for assays meeting specific ...
-
based in GERMANY
A sterilization process for a defined product has to be requalified periodically. The intervals at which requalification is carried out is determined on the basis of your risk assessment and must, if required, be justified to the monitoring ...
-
Manufactured by Creative Biolabsbased in CHINA
As new drugs are on the market constantly, the strategy to improve drug development and manufacturing processes becomes critical. In the development of pharmaceutical chemicals, it is increasingly important to improve product yields, reduce waste and cost by optimizing the reaction condition. At the same time, optimizing the reaction condition is part of a strategy to bring new chemical entities ...
-
based in AUSTRALIA
Antimicrobial Resistance (AMR) is among the greatest global health challenges of our time. AMR occurs when a micro-organism becomes resistant to an antimicrobial medicine, such as an antibiotic. Today, an estimated 700,000 people die each year from drug-resistant infections. More alarmingly, this number is projected to accelerate towards 10 million by 2050, outstripping even cancer (Review on ...
-
Manufactured by Kymab, a Sanofi companybased in UNITED KINGDOM
Our efforts in haematology are currently focussed on non-malignant blood disorders including forms of anaemia. Our approach is to identify functional and developable lead molecules and quickly proceed to verified animal disease models to study the direct impact of our drug candidates with clinically relevant read outs. We build our know-how by working on common pathways that are frequently used ...
-
by OHS Inc.based in USA
An OHS Inc. specialty is onsite drug testing: from 10 to 1,010 of your employees or your job candidates! Drug tests administered at your company's offices, job sites, or job fairs, anywhere in the ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you